Table 2. Different types of active ligands taken into in silico study, with their chemical formula and their predicted function in disrupting different stages of viral cycles.
S.No | Drug names | Chemical Formula | Viral step | References |
---|---|---|---|---|
1 | Amantadine | C10H17N | Ion channels activities | [74] |
2 | Hexamethylene Chloride | C12H30Cl2N2 | HCV particle production | [31, 74, 85] |
3 | NB-DNJ | C10H21NO4 | Folding of viral envelope and production of viral particles | [29, 39, 78] |
4 | BIT225 | C16H15N5O | Ion channels activities | [80] |
5 | Apigenin | C15H10O5 | HCV infection | [74, 86] |
6 | EGCG | C22H18O11 | Early step of entry glycoproteins (attachment)Cell-to-cell spreadClearance of cell culture | [64, 87] |
7 | Ladanein | C17H14O6 | HCV entry | [88] |
8 | Luteolin | C21H20O11 | Replication | [86] |
9 | Naringenin | C15H12O5 | AssemblySecretion (core and HCV RNA) | [89, 90] |
10 | Quercetin | C15H10O7 | HCV replicationHCV production | [91, 92] |
11 | Silymarin | C25H22O10 | Entry (fusion)ReplicationRNA and protein expression | [37, 93, 94] |
12 | Honokiol | C18H18O2 | EntryReplication | [95] |
13 | Nobelitin | C21H22O8 | Replication | [96, 97] |